IL-1 Family Cytokine Pathways Underlying NAFLD: Towards New Treatment Strategies

Research output: Contribution to journalReview articleContributedpeer-review

Contributors

  • Andreea Manuela Mirea - , Radboud University Nijmegen (Author)
  • Cees J. Tack - , Radboud University Nijmegen (Author)
  • Triantafyllos Chavakis - , Institute of Clinical Chemistry and Laboratory Medicine (Author)
  • Leo A.B. Joosten - , Radboud University Nijmegen (Author)
  • Erik J.M. Toonen - , Radboud University Nijmegen, Hycult Biotech (Author)

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Pathways responsible for the activation of IL-1 family cytokines are key in the development of NAFLD but underlying mechanisms are not fully understood. Many studies have focused on the inflammasome–caspase-1 pathway and have shown that this pathway is an important inducer of inflammation in NAFLD. However, this pathway is not solely responsible for the activation of proinflammatory cytokines. Also, neutrophil serine proteases (NSPs) are capable of activating cytokines and recent studies reported that these proteases also contribute to NAFLD. These studies provided, for the first time, evidence that this inflammasome-independent pathway is involved in NAFLD. In our opinion, these new insights open up new approaches for therapeutic intervention.

Details

Original languageEnglish
Pages (from-to)458-471
Number of pages14
JournalTrends in molecular medicine
Volume24
Issue number5
Publication statusPublished - May 2018
Peer-reviewedYes

External IDs

PubMed 29665983

Keywords

Sustainable Development Goals

ASJC Scopus subject areas

Keywords

  • inflammasome, inflammation, interleukin-1, neutrophil serine proteases, nonalcoholic fatty liver disease, obesity